Related information
by Liu, C.L. et al. This study demonstrates that a combination regimen is highly promising as a treatment option for modulating anti-FVIII antibodies and facilitating induction of long-term tolerance...
View ArticleRelated information
by Sakurai, Y. et al.Departments of Pediatrics, Nara Medical University School of Medicine, Kashihara ; Department of Pediatrics, Nara Prefectural Mimuro Hospital, Sango These results suggest that...
View ArticleRelated information
by Stennicke, H.R. et al.Novo Nordisk, Måløv, DenmarkA novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.Blood. 2013;...
View ArticleRelated information
by Zakas, P.M. et al.Graduate Program in Molecular and Systems Pharmacology, Emory University, Atlanta, United States of AmericaDevelopment and Characterization of Recombinant Ovine Coagulation Factor...
View ArticleRelated information
by Doshi, B.S. et al.Emory University School of Medicine, Atlanta, United States of AmericaPotentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of...
View ArticleRelated information
by Roth, S.D. et al.Institute for Transfusion Medicine and Immune Hematology, Clinics of the Johann Wolfgang Goethe University, German Red Cross Blood Donor Service Baden-Wuerttemberg - Hessen,...
View ArticleRelated information
by Pastoft, A.E. et al.Department of Disease Biology, Faculty of Life Science, University of Copenhagen, Copenhagen, Denmark Interestingly, the vena saphena model proved to be sensitive towards FVIII...
View ArticleRelated information
by Sack, B.K. et al.Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, United States of AmericaTransient B Cell Depletion or Improved Transgene...
View ArticleRelated information
by Chavez, C.L. et al.1 Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120 The φC31 integrase system provided a nonviral method to achieve long-term FVIII gene...
View ArticleRelated information
by Zhang, A.H. et al.Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, USAEffect of B-cell depletion using anti-CD20 therapy on inhibitory antibody...
View ArticleRelated information
by Gaitonde, P. et al.Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Amherst, USAPhosphatidylserine reduces immune response against human recombinant...
View ArticleRelated information
by Matsui, H. et al.Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, CanadaIn contrast to outcomes using this strategy to deliver FIX, this modified delivery...
View ArticleRelated information
by Qadura, M. et al.Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen's University, Kingston, CanadaImmunoglobulin isotypes and functional anti-FVIII antibodies in response...
View ArticleRelated information
by Su, R.J. et al.Puget Sound Blood Center, Seattle, Washington 98104-1256, USAThese preclinical results demonstrate the potential for using FVIII vector modified autologous ACs to treat high-titer...
View ArticleRelated information
by André, S. et al.INSERM UMRS 872, Equipe 16, Centre de Recherche des Cordeliers, 15, rue de l'Ecole de Médecine, FranceAs more information on these issues becomes available, a better understanding...
View ArticleRelated information
by Shi, Q. et al.Department of Pediatrics, Medical College of Wisconsin, Milwaukee, USASyngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in...
View ArticleRelated information
by Kallas, A. et al.Institute of Molecular and Cell Biology, University of Tartu, Riia 23, Tartu, EstoniaUsing the FVIII and FVIII in complex with VWF purified from the plasma-derived FVIII...
View Article
